Back to Search
GEORGE BEAN, M.D.
M.D.
Anatomic Pathology & Clinical Pathology Physician
NPI: 1952318354Individual
Specialties, Licenses & Credentials
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
MD-052826-L(PA)
Research & Publications (20)
A22 disrupts the bacterial actin cytoskeleton by directly binding and inducing a low-affinity state in MreB.
PMID 19382805·Biochemistry·2009
8-other
CpG island tumor suppressor promoter methylation in non-BRCA-associated early mammary carcinogenesis.
PMID 19258476·Cancer Epidemiol Biomarkers Prev·2009
8-other
Assessing the efficacy of latanoprost vs timolol using an alternate efficacy parameter: the intervisit intraocular pressure range.
PMID 19427617·Am J Ophthalmol·2009
4-observational
ESR1 promoter hypermethylation does not predict atypia in RPFNA nor persistent atypia after 12 months tamoxifen chemoprevention.
PMID 18708376·Cancer Epidemiol Biomarkers Prev·2008
8-other
Results of a study comparing the stability, efficacy, and adverse effect profile of innovator formulation, latanoprost (Xalatan) ophthalmic solution 0.005%, with that of a new formulation of a latanoprost ophthalmic solution containing cyclodextrins.
PMID 18094225·J Clin Pharmacol·2008
4-observational
Inter-visit intraocular pressure range: an alternative parameter for assessing intraocular pressure control in clinical trials.
PMID 18222194·Am J Ophthalmol·2008
4-observational
Polymerization properties of the Thermotoga maritima actin MreB: roles of temperature, nucleotides, and ions.
PMID 18095710·Biochemistry·2008
8-other
Commercially available prostaglandin analogs for the reduction of intraocular pressure: similarities and differences.
PMID 19038626·Surv Ophthalmol·2008
6-review
Hypermethylation of the breast cancer-associated gene 1 promoter does not predict cytologic atypia or correlate with surrogate end points of breast cancer risk.
PMID 17220331·Cancer Epidemiol Biomarkers Prev·2007
8-other
Morphologically normal-appearing mammary epithelial cells obtained from high-risk women exhibit methylation silencing of INK4a/ARF.
PMID 18006786·Clin Cancer Res·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 100 HOSPITAL AVE
DU BOIS, PA 15801 - Phone
- (814) 371-2200
Quick Facts
- NPI
- 1952318354
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile